189 related articles for article (PubMed ID: 24311845)
1. Nigella sativa concoction induced sustained seroreversion in HIV patient.
Onifade AA; Jewell AP; Adedeji WA
Afr J Tradit Complement Altern Med; 2013; 10(5):332-5. PubMed ID: 24311845
[TBL] [Abstract][Full Text] [Related]
2. Virologic and immunologic outcome of treatment of HIV infection with a herbal concoction, α-Zam, among clients seeking herbal remedy in Nigeria.
Onifadee AA; Jewel AP; Okesina AB
Afr J Tradit Complement Altern Med; 2011; 8(1):37-44. PubMed ID: 22238482
[TBL] [Abstract][Full Text] [Related]
3. [Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
Rey D; Schmitt MP; Hess-Kempf G; Krantz V; Partisani M; Bernard-Henry C; Lang JM
Pathol Biol (Paris); 2001 Sep; 49(7):559-66. PubMed ID: 11642019
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infection.
Usha PR; Naidu MU; Raju YS
Drugs R D; 2003; 4(2):103-9. PubMed ID: 12718564
[TBL] [Abstract][Full Text] [Related]
5. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
6. Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART.
Re MC; Ramazzotti E; Manfredi R; Furlini G; Vignoli M; Maldini C; Borderi M; La Placa M
J Clin Virol; 2000 Jun; 17(1):5-11. PubMed ID: 10814933
[TBL] [Abstract][Full Text] [Related]
7. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C;
PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242
[TBL] [Abstract][Full Text] [Related]
8. Effects of Nigella sativa on outcome of hepatitis C in Egypt.
Barakat EM; El Wakeel LM; Hagag RS
World J Gastroenterol; 2013 Apr; 19(16):2529-36. PubMed ID: 23674855
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
[TBL] [Abstract][Full Text] [Related]
10. Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study).
Castagna A; Muccini C; Galli L; Bigoloni A; Poli A; Spagnuolo V; Nozza S; Racca S; Galli A; Cinque P; Carini E; Lazzarin A
J Antimicrob Chemother; 2019 Jul; 74(7):2039-2046. PubMed ID: 31225610
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
12. [Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy].
Zhao HX; Zhang FJ; Han N; Lan MD; Yao J; Liu ZY; Lu LH; Wei HS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):658-61. PubMed ID: 17121226
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
14. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.
Ormaasen V; Bruun JN; Sandvik L; Holberg-Petersen M; Gaarder PI
Scand J Infect Dis; 2003; 35(6-7):383-8. PubMed ID: 12953949
[TBL] [Abstract][Full Text] [Related]
16. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
AIDS; 1998 Nov; 12(16):2193-202. PubMed ID: 9833861
[TBL] [Abstract][Full Text] [Related]
17. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
18. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy for HIV-2 infected patients.
Smith NA; Shaw T; Berry N; Vella C; Okorafor L; Taylor D; Ainsworth J; Choudhury A; Daniels RS; El-Gadi S; Fakoya A; Moyle G; Oxford J; Tedder R; O'Shea S; de Ruiter A; Breuer J
J Infect; 2001 Feb; 42(2):126-33. PubMed ID: 11531319
[TBL] [Abstract][Full Text] [Related]
20. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN
AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
